Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 31 04:00PM ET
4.14
Dollar change
-0.08
Percentage change
-1.90
%
Index- P/E- EPS (ttm)-4.19 Insider Own15.51% Shs Outstand32.02M Perf Week5.08%
Market Cap132.54M Forward P/E- EPS next Y-1.28 Insider Trans3.64% Shs Float27.05M Perf Month13.11%
Income-108.44M PEG- EPS next Q-0.74 Inst Own10.99% Short Float6.42% Perf Quarter126.23%
Sales490.74M P/S0.27 EPS this Y54.97% Inst Trans-15.03% Short Ratio2.35 Perf Half Y157.14%
Book/sh6.55 P/B0.63 EPS next Y32.16% ROA-12.77% Short Interest1.74M Perf Year12.81%
Cash/sh0.67 P/C6.18 EPS next 5Y- ROE-49.33% 52W Range1.23 - 11.42 Perf YTD12.81%
Dividend Est.- P/FCF- EPS past 5Y-122.90% ROI-18.06% 52W High-63.74% Beta3.60
Dividend TTM- Quick Ratio0.91 Sales past 5Y117.65% Gross Margin11.01% 52W Low237.41% ATR (14)0.65
Dividend Ex-Date- Current Ratio1.37 EPS Y/Y TTM-2.07% Oper. Margin-15.54% RSI (14)50.14 Volatility12.57% 16.93%
Employees2075 Debt/Eq2.61 Sales Y/Y TTM-14.27% Profit Margin-22.10% Recom1.67 Target Price6.67
Option/ShortYes / Yes LT Debt/Eq2.52 EPS Q/Q-93.55% Payout- Rel Volume0.82 Prev Close4.22
Sales Surprise11.53% EPS Surprise25.13% Sales Q/Q-7.33% EarningsDec 03 AMC Avg Volume739.35K Price4.14
SMA20-8.02% SMA5023.47% SMA20032.75% Trades Volume606,602 Change-1.90%
Date Action Analyst Rating Change Price Target Change
May-14-24Downgrade Jefferies Buy → Hold $11.50 → $3.75
Feb-09-24Upgrade Jefferies Hold → Buy $3 → $11.50
Jul-20-23Initiated Wells Fargo Overweight $9
Jan-19-23Downgrade Jefferies Buy → Hold $10 → $8
Jan-11-23Upgrade Lake Street Hold → Buy $4 → $10
Nov-18-22Downgrade Lake Street Buy → Hold $60 → $7
Oct-04-22Initiated Jefferies Buy $27
Jan-31-22Initiated Lake Street Buy $60
Sep-20-21Initiated Craig Hallum Buy $45
Dec-30-24 04:05PM
Dec-23-24 04:05PM
Dec-18-24 08:00AM
Dec-17-24 04:03PM
Dec-04-24 02:00AM
04:05PM Loading…
Dec-03-24 04:05PM
Dec-02-24 07:02AM
Nov-21-24 08:30AM
Nov-20-24 04:05PM
Nov-07-24 08:00AM
Oct-09-24 05:54PM
Sep-16-24 08:00AM
Aug-28-24 04:05PM
Aug-08-24 06:15PM
04:05PM
08:00AM Loading…
Jul-25-24 08:00AM
Jul-09-24 06:50AM
Jul-01-24 10:20AM
Jun-10-24 07:30AM
Jun-03-24 02:49PM
01:24PM
May-23-24 04:15PM
May-15-24 09:54PM
04:05PM
May-14-24 08:19AM
07:34AM
07:00AM
May-10-24 05:20AM
May-09-24 06:56PM
Apr-29-24 04:05PM
08:50AM Loading…
Apr-03-24 08:50AM
Apr-02-24 08:50AM
Mar-25-24 09:40AM
Mar-18-24 08:50AM
Mar-12-24 04:42PM
Mar-07-24 04:20PM
12:00PM
08:50AM
Mar-01-24 09:40AM
Feb-29-24 08:50AM
Feb-27-24 01:34PM
Feb-20-24 07:38AM
Feb-19-24 08:50AM
Feb-14-24 09:40AM
Feb-09-24 08:25AM
Feb-08-24 09:55AM
08:54AM
Feb-07-24 06:10PM
04:05PM
Jan-29-24 04:05PM
Jan-27-24 09:00AM
Dec-16-23 03:01PM
Dec-15-23 08:50AM
Dec-14-23 08:14AM
Dec-12-23 07:45AM
Dec-11-23 09:54PM
04:05PM
Dec-06-23 04:30PM
Nov-27-23 04:05PM
Nov-13-23 04:05PM
Nov-08-23 07:30AM
Nov-01-23 08:00AM
Oct-16-23 08:00AM
Aug-29-23 06:47PM
Aug-24-23 04:05PM
Aug-15-23 03:31PM
Aug-10-23 06:15PM
04:08PM
Jul-24-23 04:35PM
Jul-20-23 08:24PM
Jun-30-23 08:44AM
Jun-05-23 09:55AM
May-30-23 08:50AM
May-25-23 08:33AM
May-19-23 08:33AM
May-18-23 09:55AM
May-13-23 08:15AM
May-11-23 05:55PM
04:05PM
May-08-23 08:18AM
06:27AM
May-04-23 08:33AM
Apr-26-23 08:33AM
Apr-11-23 09:00AM
07:27AM
Mar-24-23 08:38AM
Mar-22-23 03:45AM
Mar-15-23 07:00AM
Mar-03-23 05:30AM
Feb-27-23 06:50AM
Feb-22-23 03:23AM
Feb-14-23 04:45PM
Feb-13-23 04:05PM
Feb-06-23 10:45PM
Feb-01-23 01:15PM
Jan-23-23 04:40PM
Jan-12-23 12:29PM
Jan-10-23 04:05PM
Jan-04-23 04:30PM
Dec-15-22 08:16AM
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. It operates under the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments. The DSA segment focuses on drug discovery and development services. The RMS segment includes commercial production and selling research models, diets, bedding, and bioproducts. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Landman DavidDirectorDec 19 '24Buy4.2523,52999,998176,851Dec 23 09:47 PM
Beattie John GregoryChief Operating OfficerDec 10 '24Buy4.7530,000142,500161,761Dec 12 06:46 PM
Brown NigelDirectorDec 10 '24Buy4.267,50031,95065,537Dec 10 04:13 PM
Harrington Michael JDirectorDec 06 '24Buy3.9810,00039,82237,500Dec 10 08:34 AM
Landman DavidDirectorDec 06 '24Buy4.14100,000414,000153,322Dec 10 08:31 AM
ELAN Elanco Animal Health Inc daily Stock Chart
Index- P/E29.64 EPS (ttm)0.41 Insider Own1.49% Shs Outstand494.33M Perf Week2.11%
Market Cap5.99B Forward P/E13.31 EPS next Y0.91 Insider Trans1.39% Shs Float486.97M Perf Month-8.33%
Income205.00M PEG2.96 EPS next Q0.15 Inst Own98.03% Short Float3.21% Perf Quarter-16.48%
Sales4.45B P/S1.34 EPS this Y2.89% Inst Trans-0.24% Short Ratio3.56 Perf Half Y-13.56%
Book/sh13.20 P/B0.92 EPS next Y-0.61% ROA1.48% Short Interest15.63M Perf Year-18.72%
Cash/sh0.99 P/C12.22 EPS next 5Y10.00% ROE3.24% 52W Range11.40 - 18.80 Perf YTD-18.72%
Dividend Est.- P/FCF15.75 EPS past 5Y- ROI1.89% 52W High-35.59% Beta1.41
Dividend TTM- Quick Ratio1.31 Sales past 5Y9.00% Gross Margin42.68% 52W Low6.23% ATR (14)0.42
Dividend Ex-Date- Current Ratio2.55 EPS Y/Y TTM117.83% Oper. Margin5.68% RSI (14)45.06 Volatility2.71% 3.72%
Employees9800 Debt/Eq0.67 Sales Y/Y TTM1.92% Profit Margin4.60% Recom1.81 Target Price18.08
Option/ShortYes / Yes LT Debt/Eq0.66 EPS Q/Q132.88% Payout- Rel Volume0.54 Prev Close11.82
Sales Surprise-0.61% EPS Surprise6.21% Sales Q/Q-3.56% EarningsNov 07 BMO Avg Volume4.39M Price12.11
SMA20-0.44% SMA50-5.31% SMA200-15.90% Trades Volume2,415,221 Change2.45%
Date Action Analyst Rating Change Price Target Change
Dec-09-24Initiated UBS Buy $18
Dec-02-24Initiated Leerink Partners Market Perform $14
Sep-19-24Downgrade Morgan Stanley Overweight → Equal-Weight $17 → $15
Jan-05-24Upgrade Stifel Hold → Buy $13 → $20
Dec-19-23Initiated Jefferies Buy $17
Dec-15-23Upgrade Morgan Stanley Equal-Weight → Overweight $16
Dec-07-23Initiated Exane BNP Paribas Outperform $18
Apr-20-23Upgrade Barclays Equal Weight → Overweight $14
Aug-18-22Downgrade Morgan Stanley Overweight → Equal-Weight $37 → $22
Aug-16-22Downgrade JP Morgan Overweight → Neutral $28 → $24
Dec-19-24 11:07AM
Dec-01-24 09:08AM
Nov-29-24 12:18PM
Nov-27-24 01:45PM
Nov-26-24 07:22AM
04:31AM Loading…
04:31AM
Nov-25-24 08:45AM
08:00AM
Nov-24-24 11:33AM
Nov-23-24 07:23AM
Nov-21-24 10:46AM
Nov-20-24 08:53AM
Nov-18-24 02:52PM
Nov-15-24 11:30AM
Nov-14-24 03:15PM
01:39PM Loading…
Nov-13-24 01:39PM
Nov-12-24 07:20PM
08:33AM
05:45AM
Nov-11-24 04:02PM
Nov-08-24 04:03AM
02:09AM
02:03AM
Nov-07-24 04:30PM
03:28PM
12:41PM
09:30AM
08:52AM
07:35AM
06:27AM
07:38AM Loading…
Nov-05-24 07:38AM
Nov-04-24 03:51PM
09:16AM
Nov-01-24 05:45AM
Oct-31-24 01:42PM
10:01AM
Oct-30-24 11:46AM
Oct-28-24 07:17PM
Oct-25-24 09:56AM
Oct-24-24 02:29PM
Oct-23-24 10:16AM
Oct-22-24 10:42AM
Oct-21-24 06:12PM
Oct-17-24 12:14PM
12:10PM
Oct-16-24 11:21AM
08:54AM
Oct-11-24 09:14AM
Oct-10-24 08:00AM
Oct-09-24 11:23AM
Oct-08-24 08:43PM
Oct-07-24 04:19PM
Sep-20-24 10:35AM
Sep-19-24 03:08PM
01:42PM
12:50PM
Sep-13-24 07:30AM
Aug-28-24 06:30AM
Aug-20-24 06:27AM
Aug-15-24 08:27AM
Aug-13-24 01:49PM
Aug-09-24 02:35AM
Aug-08-24 03:45PM
09:30AM
07:35AM
06:28AM
Aug-06-24 01:00PM
Aug-05-24 09:16AM
Aug-01-24 03:14PM
10:01AM
Jul-30-24 08:27AM
Jul-25-24 01:18PM
Jul-22-24 02:42PM
10:18AM
Jul-18-24 08:00AM
Jul-15-24 03:20PM
Jul-12-24 12:04PM
Jul-10-24 03:22PM
01:23PM
Jul-09-24 08:30AM
08:28AM
Jul-08-24 02:09PM
Jun-27-24 04:12PM
06:27AM
Jun-07-24 12:00PM
Jun-06-24 08:00AM
May-28-24 07:30PM
06:27AM
May-24-24 02:39AM
May-23-24 04:03PM
May-21-24 08:00AM
May-13-24 09:17AM
May-09-24 08:54PM
11:33AM
10:26AM
09:44AM
07:43AM
03:05AM
May-08-24 04:04PM
02:00PM
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Harrington Michael JDirectorAug 22 '24Buy14.853,50051,97481,094Aug 26 05:05 PM
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORAug 12 '24Buy13.01100,0001,300,610145,000Aug 13 09:04 AM
DOYLE WILLIAM FDirectorMay 21 '24Buy16.9815,000254,70076,330May 23 04:33 PM
DOYLE WILLIAM FDirectorMar 08 '24Buy16.3015,000244,50061,330Mar 12 04:32 PM
Harrington Michael JDirectorMar 08 '24Buy16.293,10050,49477,594Mar 12 04:30 PM
HOOVER R DAVIDDirectorMar 06 '24Buy16.1420,000322,808185,000Mar 08 05:09 PM